Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT07361094 · RECRUITING

Trial details

NCT number: NCT07361094
Sponsor: Beijing Boren Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Systemic Lupus Erythematosus Relapsed/Refractory Systemic Sclerosis Relapsed/Refractory Idiopathic Inflammatory Myopathies Relapsed/Refractory sjögren's Syndrome Relapsed/Refractory Autoimmune Hemolytic Anemia Relapsed/Refractory Multiple Sclerosis

Start date: 2025-11-06
Primary completion: 2028-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.